Cargando…

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review

OBJECTIVE: To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs). DESIGN/SETTING: We conducted a systematic review of studies exploring/assessing patient, info...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunner, Laureline, Rodondi, Nicolas, Aubert, Carole Elodie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791375/ https://www.ncbi.nlm.nih.gov/pubmed/36549739 http://dx.doi.org/10.1136/bmjopen-2022-061686

Ejemplares similares

Barriers and facilitators to deprescribing in primary care: a systematic review
por: Doherty, Alison Jayne, et al.
Publicado: (2020)

Understanding the barriers and facilitators that influence access to quality cardiovascular care for rural Indigenous peoples: protocol for a scoping review
por: Tane, Taria, et al.
Publicado: (2022)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum
por: Jamison, James, et al.
Publicado: (2017)

The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
por: Rasmussen, Anja Fog, et al.
Publicado: (2021)

Editorial: Micro- and macronutrient malnutrition in cardiovascular disease
por: Hobkirk, J. P., et al.
Publicado: (2023)

Barriers, Enablers and Strategies for the Treatment and Control of Hypertension in Nepal: A Systematic Review
por: Dhungana, Raja Ram, et al.
Publicado: (2021)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020)

Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing
por: Linsky, Amy, et al.
Publicado: (2017)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Health literacy and cardiovascular disease prevention: a systematic scoping review protocol
por: Beasant, Bonnie, et al.
Publicado: (2022)

Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis
por: Kosciuszek, Nina D., et al.
Publicado: (2022)

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes
por: Fan, Jie-Fu, et al.
Publicado: (2023)

Perceived health system facilitators and barriers to integrated management of hypertension and type 2 diabetes in Kenya: a qualitative study
por: Otieno, Peter, et al.
Publicado: (2023)

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study
por: Ramsdale, Erika, et al.
Publicado: (2023)

Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
por: Studzin´ski, Krzysztof, et al.
Publicado: (2017)

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis
por: Fabunmi, Oyesanmi A., et al.
Publicado: (2023)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review
por: Usher-Smith, Juliet A, et al.
Publicado: (2015)

Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Tianyi, et al.
Publicado: (2021)

Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
por: Mansilla-Rodríguez, María Elena, et al.
Publicado: (2023)

Clinical practice guidelines for cardiovascular disease: how is depression addressed? Protocol for a systematic review
por: Blatch Armon, Dana, et al.
Publicado: (2023)

Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study
por: Jaworska, Natalia, et al.
Publicado: (2023)

Burden of disease and barriers to comprehensive care for rheumatic heart disease in South Africa: an updated systematic review protocol
por: Murugasen, Serini, et al.
Publicado: (2023)

Does Tai Chi improve psychological well-being and quality of life in patients with cardiovascular disease and/or cardiovascular risk factors? A systematic review protocol
por: Yang, Guoyan, et al.
Publicado: (2017)

Effects of lifestyle interventions on cardiovascular risk factors in South Asians: a systematic review and meta-analysis
por: Limbachia, Jayneel, et al.
Publicado: (2022)

The Association Between Monocyte Subsets and Cardiometabolic Disorders/Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Oh, Ester S., et al.
Publicado: (2021)

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Lee, Jane J., et al.
Publicado: (2021)

Study title: A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use
por: Kim, Mimi M., et al.
Publicado: (2023)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Strategies for enhancing the initiation of cholesterol lowering medication among patients at high cardiovascular disease risk: a qualitative descriptive exploration of patient and general practitioners’ perspectives on a facilitated relay intervention in Alberta, Canada
por: Campbell, David J T, et al.
Publicado: (2020)

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis
por: Ye, Zhen, et al.
Publicado: (2022)

Barriers and facilitators to return to work following cardiovascular disease: a systematic review and meta-synthesis of qualitative research
por: Andersen, Emma Borre, et al.
Publicado: (2023)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Evidence for overuse of cardiovascular healthcare services in high-income countries: protocol for a systematic review and meta-analysis
por: Roberts, Derek J, et al.
Publicado: (2022)

Does intermittent exposure to high altitude increase the risk of cardiovascular disease in workers? A systematic narrative review
por: Aragón-Vela, Jerónimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_80egguje3n664mihjeirc8bbl2